table of content
1 Introduction to Research & Analysis Reports
1.1 Urological Cancer Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urological Cancer Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urological Cancer Therapeutics Drugs Overall Market Size
2.1 Global Urological Cancer Therapeutics Drugs Market Size: 2021 VS 2028
2.2 Global Urological Cancer Therapeutics Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Urological Cancer Therapeutics Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Urological Cancer Therapeutics Drugs Players in Global Market
3.2 Top Global Urological Cancer Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Urological Cancer Therapeutics Drugs Revenue by Companies
3.4 Global Urological Cancer Therapeutics Drugs Sales by Companies
3.5 Global Urological Cancer Therapeutics Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Urological Cancer Therapeutics Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Urological Cancer Therapeutics Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Urological Cancer Therapeutics Drugs Players in Global Market
3.8.1 List of Global Tier 1 Urological Cancer Therapeutics Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Urological Cancer Therapeutics Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Urological Cancer Therapeutics Drugs Market Size Markets, 2021 & 2028
4.1.2 Xofigo (radium Ra 223 dichloride)
4.1.3 Jevtana (cabazitaxel)
4.1.4 Inlyta (axitinib)
4.1.5 Votrient (pazopanib hydrochloride)
4.1.6 Sutent (sunitinib malate)
4.1.7 Zytiga (abiraterone acetate)
4.1.8 Xtandi (enzalutamide)
4.1.9 Opdivo (nivolumab)
4.1.10 Provenge (sipuleucel-T)
4.2 By Type - Global Urological Cancer Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Urological Cancer Therapeutics Drugs Revenue, 2017-2022
4.2.2 By Type - Global Urological Cancer Therapeutics Drugs Revenue, 2023-2028
4.2.3 By Type - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Urological Cancer Therapeutics Drugs Sales & Forecasts
4.3.1 By Type - Global Urological Cancer Therapeutics Drugs Sales, 2017-2022
4.3.2 By Type - Global Urological Cancer Therapeutics Drugs Sales, 2023-2028
4.3.3 By Type - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Urological Cancer Therapeutics Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Urological Cancer Therapeutics Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Medical Research Laboratory
5.1.4 Others
5.2 By Application - Global Urological Cancer Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Urological Cancer Therapeutics Drugs Revenue, 2017-2022
5.2.2 By Application - Global Urological Cancer Therapeutics Drugs Revenue, 2023-2028
5.2.3 By Application - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Urological Cancer Therapeutics Drugs Sales & Forecasts
5.3.1 By Application - Global Urological Cancer Therapeutics Drugs Sales, 2017-2022
5.3.2 By Application - Global Urological Cancer Therapeutics Drugs Sales, 2023-2028
5.3.3 By Application - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Urological Cancer Therapeutics Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Urological Cancer Therapeutics Drugs Market Size, 2021 & 2028
6.2 By Region - Global Urological Cancer Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Urological Cancer Therapeutics Drugs Revenue, 2017-2022
6.2.2 By Region - Global Urological Cancer Therapeutics Drugs Revenue, 2023-2028
6.2.3 By Region - Global Urological Cancer Therapeutics Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Urological Cancer Therapeutics Drugs Sales & Forecasts
6.3.1 By Region - Global Urological Cancer Therapeutics Drugs Sales, 2017-2022
6.3.2 By Region - Global Urological Cancer Therapeutics Drugs Sales, 2023-2028
6.3.3 By Region - Global Urological Cancer Therapeutics Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Urological Cancer Therapeutics Drugs Revenue, 2017-2028
6.4.2 By Country - North America Urological Cancer Therapeutics Drugs Sales, 2017-2028
6.4.3 US Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.4.4 Canada Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.4.5 Mexico Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Urological Cancer Therapeutics Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Urological Cancer Therapeutics Drugs Sales, 2017-2028
6.5.3 Germany Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5.4 France Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5.5 U.K. Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5.6 Italy Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5.7 Russia Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.5.9 Benelux Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Urological Cancer Therapeutics Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Urological Cancer Therapeutics Drugs Sales, 2017-2028
6.6.3 China Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.6.4 Japan Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.6.5 South Korea Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.6.7 India Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Urological Cancer Therapeutics Drugs Revenue, 2017-2028
6.7.2 By Country - South America Urological Cancer Therapeutics Drugs Sales, 2017-2028
6.7.3 Brazil Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.7.4 Argentina Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Urological Cancer Therapeutics Drugs Sales, 2017-2028
6.8.3 Turkey Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.8.4 Israel Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Urological Cancer Therapeutics Drugs Market Size, 2017-2028
6.8.6 UAE Urological Cancer Therapeutics Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Urological Cancer Therapeutics Drugs Major Product Offerings
7.1.4 Novartis Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Urological Cancer Therapeutics Drugs Major Product Offerings
7.2.4 Pfizer Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Major Product Offerings
7.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Major Product Offerings
7.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Astellas
7.5.1 Astellas Corporate Summary
7.5.2 Astellas Business Overview
7.5.3 Astellas Urological Cancer Therapeutics Drugs Major Product Offerings
7.5.4 Astellas Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Astellas Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Bristol-Myers Squibb Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Major Product Offerings
7.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Abbott Laboratories Key News
7.8 Celgene Corporation
7.8.1 Celgene Corporation Corporate Summary
7.8.2 Celgene Corporation Business Overview
7.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Major Product Offerings
7.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Celgene Corporation Key News
7.9 Dendreon Corporation
7.9.1 Dendreon Corporation Corporate Summary
7.9.2 Dendreon Corporation Business Overview
7.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Major Product Offerings
7.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Dendreon Corporation Key News
7.10 Ferring Pharmaceuticals
7.10.1 Ferring Pharmaceuticals Corporate Summary
7.10.2 Ferring Pharmaceuticals Business Overview
7.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Major Product Offerings
7.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Ferring Pharmaceuticals Key News
7.11 GlaxoSmithKline plc
7.11.1 GlaxoSmithKline plc Corporate Summary
7.11.2 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Business Overview
7.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Major Product Offerings
7.11.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.11.5 GlaxoSmithKline plc Key News
7.12 Indevus Pharmaceuticals Inc
7.12.1 Indevus Pharmaceuticals Inc Corporate Summary
7.12.2 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Business Overview
7.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Major Product Offerings
7.12.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Indevus Pharmaceuticals Inc Key News
7.13 Ipsen
7.13.1 Ipsen Corporate Summary
7.13.2 Ipsen Urological Cancer Therapeutics Drugs Business Overview
7.13.3 Ipsen Urological Cancer Therapeutics Drugs Major Product Offerings
7.13.4 Ipsen Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Ipsen Key News
7.14 Roche Healthcare
7.14.1 Roche Healthcare Corporate Summary
7.14.2 Roche Healthcare Business Overview
7.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Major Product Offerings
7.14.4 Roche Healthcare Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Roche Healthcare Key News
7.15 Sanofi S.A.
7.15.1 Sanofi S.A. Corporate Summary
7.15.2 Sanofi S.A. Business Overview
7.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Major Product Offerings
7.15.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Sanofi S.A. Key News
8 Global Urological Cancer Therapeutics Drugs Production Capacity, Analysis
8.1 Global Urological Cancer Therapeutics Drugs Production Capacity, 2017-2028
8.2 Urological Cancer Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Urological Cancer Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Urological Cancer Therapeutics Drugs Supply Chain Analysis
10.1 Urological Cancer Therapeutics Drugs Industry Value Chain
10.2 Urological Cancer Therapeutics Drugs Upstream Market
10.3 Urological Cancer Therapeutics Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Urological Cancer Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
